Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
Stem Cell Research & Therapy|July 2, 2025
Salvage treatment of steroid-refractory acute GVHD with the off-the-shelf product of human umbilical cord mesenchymal stromal cells: a multicenter, open label, phase Ib/IIa trialYanmin Zhao, Yi Luo, Jimin Shi, et al.Cell Transplantation|February 12, 2026
Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantationXiaolin Yuan, Yibo Wu, Tingting Yang, et al.Annals of Hematology|April 18, 2024
Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCTLingxia Cai, Diange Jin, Jianbo Lai, et al.Cell Transplantation|January 25, 2024
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic FactorsBingqian Jiang, Yanmin Zhao, Yi Luo, et al.Cancer|June 18, 2025
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemiaYibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.Journal of Translational Medicine|April 30, 2024
Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective studyWeihao Chen, Jingtao Huang, Yeqian Zhao, et al.Bone Marrow Transplantation|January 9, 2026
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world studyYibo Wu, Xiaolin Yuan, Lieguang Chen, et al.Clinical & Translational Immunology|July 4, 2025
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.The Lancet. Haematology|July 30, 2026
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trialHengwei Wu, Wenming Shi, Zhuoyue Shi, et al.Annals of Hematology|July 4, 2024
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysisJing Zheng, Yanmin Zhao, Yi Luo, et al.Pageof 15